The Golgi apparatus: Site for convergence of COVID-19 brain fog and Alzheimer's disease?
Journal Information
Full Title: Mol Neurodegener
Abbreviation: Mol Neurodegener
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Molecular Biology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflict of interestY.W. is a founder of Camillo, Inc., a biotechnology company focusing on the potential use of GRASPs and other Golgi structural proteins as treatments for neurodegenerative diseases. Conflict of interest Y.W. is a founder of Camillo, Inc., a biotechnology company focusing on the potential use of GRASPs and other Golgi structural proteins as treatments for neurodegenerative diseases."
" The authors wish to thank Dr. Jianchao Zhang and other members of the Wang, Ehrlich-Gandy, and Tortorella labs for stimulating discussions. Y.W. is supported by NIH/NIGMS (R35GM130331) and the Fast Forward Protein Folding Disease Initiative of the University of Michigan. S.G. is supported by RF1AG058469, RF1AG059319, U01AG046170, R01AG061894, and P30 AG066514 (to Mary Sano)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025